Cara Therapeutics Stock Price - CARA

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 17.33 ▲ 0.02 (0.14%)
Company Name Stock Ticker Symbol Market Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.415 2.46% 17.305 17.36 16.93 17.05 16.89 00:00:07
Bid Price Ask Price Spread Spread % News
10.12 18.18 8.06 44.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,316 686,011 $ 17.16 $ 11,774,820 829,834 14.10 - 27.55
Last Trade Time Type Quantity Stock Price Currency
17:45:39 priorref 7,413 $ 17.305 USD

Cara Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 807.78M 46.68M $ -74.01M -2.06 - 45.26M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cara Therapeutics News

Loading Messages....

Latest CARA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CARA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week15.4817.3615.2316.30676,1231.8311.79%
1 Month16.5117.3614.77516.08661,0190.7954.82%
3 Months19.9226.6714.77518.09720,227-2.62-13.13%
6 Months26.2527.5514.77520.40713,137-8.95-34.08%
1 Year15.2827.5514.1019.87705,6162.0313.25%
3 Years11.4428.5011.0316.981,101,4745.8751.27%
5 Years10.6928.504.2615.04895,9236.6261.88%

Cara Therapeutics Description

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.


Your Recent History
NASDAQ
CARA
Cara Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.